Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | PGK1 | P00558 | 6/20 | 0.40 |
| ▸ | PGK2 | P07205 | 6/20 | 0.40 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.37 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ACP3 | P15309 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9301497 | 0.82 | SRC (0.75) | SRCPGK1PGK2ACP3 | |
| SCHEMBL4881249 | 0.80 | ALDH1A1 (0.42) | ALDH1A1TDP1PGK1PGK2TAS1R3 | |
| SCHEMBL5058077 | 0.77 | ACP3 (0.40) | ALDH1A1TDP1PGK1PGK2TAS1R3 | |
| SCHEMBL2171583 | 0.75 | SRC (0.65) | SRCPGK1PGK2ACP3 | |
| SCHEMBL5936840 | 0.73 | SRC (0.62) | SRCALDH1A1TDP1PGK1PGK2 | |
| SCHEMBL19273327 | 0.72 | ALDH1A1 (0.61) | ALDH1A1TDP1TAS1R3TAS1R1TSHR | |
| SCHEMBL30083976 | 0.72 | ALDH1A1 (0.61) | ALDH1A1TDP1TAS1R3TAS1R1TSHR | |
| SCHEMBL744205 | 0.71 | SRC (0.60) | SRCALDH1A1PGK1PGK2ACP3 | |
| SCHEMBL4093802 | 0.71 | SRC (0.60) | SRCTDP1PGK1PGK2TSHR | |
| SCHEMBL1552133 | 0.71 | SRC (0.60) | SRCPGK1PGK2TSHRACP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2852600-B1 | BISPHOSPHONATES VINYLIC MONOMERS AND POLYMERS AND USES THEREOF | UNIV BAR ILAN (IL) | 2021-10-13 | — | — | EP | disclosed |
| US-20180155374-A1 | BISPHOSPHONATES VINYLIC MONOMERS AND POLYMERS AND USES THEREOF | BAR-ILAN UNIVERSITY | 2018-06-07 | — | — | US | disclosed |
| US-9690192-B2 | Composition for base, and directed self-assembly lithography method | JSR CORPORATION (JP) | 2017-06-27 | — | — | US | disclosed |
| EP-2852600-A1 | BISPHOSPHONATES VINYLIC MONOMERS AND POLYMERS AND USES THEREOF | Bar Ilan Research&Development Company Ltd. (IL) | 2015-04-01 | — | — | EP | disclosed |
| WO-2013175385-A1 | BISPHOSPHONATES VINYLIC MONOMERS AND POLYMERS AND USES THEREOF | BAR-ILAN RESEARCH AND DEVELOPMENT COMPANY LTD. (IL) | 2013-11-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180155374-A1 | BISPHOSPHONATES VINYLIC MONOMERS AND POLYMERS AND USES THEREOF | PTH1R, PITHD1, VCL | SRC 539/4885ALDH1A1 4450/4885TDP1 4567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.